<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02000115</url>
  </required_header>
  <id_info>
    <org_study_id>1203</org_study_id>
    <nct_id>NCT02000115</nct_id>
  </id_info>
  <brief_title>Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial</brief_title>
  <acronym>PORTICO-IDE</acronym>
  <official_title>Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the PORTICO pivotal IDE trial is to evaluate the safety and effectiveness of&#xD;
      the St Jude Medical (SJM) Portico Transcatheter Heart Valve and Delivery Systems (Portico) in&#xD;
      the treatment of severe symptomatic aortic stenosis via transfemoral and alternative delivery&#xD;
      methods in high risk and extreme risk patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PORTICO pivotal IDE trial will include a randomized cohort of 750 subjects enrolled at up&#xD;
      to 70 investigational sites in the United States and Australia. Patients will be randomized&#xD;
      (1:1) to receive the SJM Portico Transcatheter Heart Valve and Delivery Systems (Portico) or&#xD;
      any FDA-approved, commercially-available Transcatheter Aortic Valve Replacement (TAVR)&#xD;
      System. The randomized cohort will be tested for two co-primary endpoints at 30 days (primary&#xD;
      safety endpoint) and 1 year (primary effectiveness endpoint). At the time of the primary&#xD;
      randomized cohort analysis, the risk cohorts will be combined and analysis will be conducted&#xD;
      on the intention-to-treat (n=750) population.&#xD;
&#xD;
      The FlexNav Delivery System study will be conducted as a separate arm of the PORTICO IDE&#xD;
      trial and will include up to 200 high or extreme risk subjects; including a minimum of 100&#xD;
      analysis subjects. The study will characterize the safety of the next-generation Portico&#xD;
      Delivery System (&quot;FlexNav™ Delivery System&quot;). The primary analysis cohort will include&#xD;
      FlexNav analysis subjects.&#xD;
&#xD;
      The IDE Valve-in-Valve registry will enroll up to 100 high or extreme risk subjects with a&#xD;
      failed surgical bioprosthesis who are eligible to receive a Portico Transcatheter Heart&#xD;
      Valve.&#xD;
&#xD;
      All subjects enrolled in the PORTICO pivotal IDE trial will undergo follow-up at baseline,&#xD;
      peri- and post-procedure, at discharge or 7 days post-procedure (whichever comes first), 30&#xD;
      days, 6 months, 12-months and then annually through 5-years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Actual">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Effectiveness Endpoint (Randomized IDE Cohort)</measure>
    <time_frame>One-year from randomization</time_frame>
    <description>A composite of all-cause mortality or disabling stroke at one year.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Endpoint (Randomized IDE Cohort)</measure>
    <time_frame>30 days from randomization</time_frame>
    <description>Non-hierarchical composite of all-cause mortality, disabling stroke, life threatening bleeding requiring blood transfusion, acute kidney injury requiring dialysis, or major vascular complications at 30 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Patients With Major Vascular Complications (Primary Safety Endpoint- FlexNav Delivery System Study)</measure>
    <time_frame>30 days from index procedure</time_frame>
    <description>Valve Academic Research Consortium (VARC) 2- defined major vascular complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With Severe Aortic Regurgitation (Randomized IDE Cohort)</measure>
    <time_frame>One year</time_frame>
    <description>Severe aortic regurgitation (AR) at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score (Randomized IDE Cohort)</measure>
    <time_frame>One year</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) at one year. Scale 0 to 100; with higher scores indicating better symptoms and physical functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With Moderate or Severe Aortic Regurgitation (Randomized IDE Cohort)</measure>
    <time_frame>One year</time_frame>
    <description>Moderate or severe aortic regurgitation at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-Minute Walk Test- Total Distance Walked (Randomized IDE Cohort)</measure>
    <time_frame>One year</time_frame>
    <description>Six-minute walk distance at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With Composite Safety Endpoint (Nested Valve-in-Valve Registry)</measure>
    <time_frame>30 days from index procedure</time_frame>
    <description>Non-hierarchical composite of all-cause mortality, disabling stroke, life threatening bleeding requiring blood transfusion, acute kidney injury requiring dialysis, or major vascular complications at 30 days from index procedure.&#xD;
Anticipated completion date (2022)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With All-cause Mortality or Disabling Stroke (Nested Valve-in-Valve Registry)</measure>
    <time_frame>One year from index procedure</time_frame>
    <description>A composite of all-cause mortality or disabling stroke at one year Anticipated completion data (2023)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Randomized IDE Cohort, Portico Valve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Portico transcatheter aortic valve and Portico delivery system.&#xD;
Status: ACTIVE, NOT ENROLLING.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized IDE Cohort, CAV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).&#xD;
Status: ACTIVE, NOT ENROLLING.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nested Valve-in-Valve Registry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who have documented failed aortic surgical valve prosthesis and are deemed eligible to receive a transcatheter Portico valve&#xD;
Status: ACTIVE, ENROLLING.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FlexNav Delivery System Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Portico transcatheter aortic valve and FlexNav delivery system&#xD;
Status: ACTIVE, NOT ENROLLING</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Portico transcatheter aortic valve</intervention_name>
    <description>St. Jude Medical transcatheter Portico aortic valve</description>
    <arm_group_label>FlexNav Delivery System Study</arm_group_label>
    <arm_group_label>Nested Valve-in-Valve Registry</arm_group_label>
    <arm_group_label>Randomized IDE Cohort, Portico Valve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Commercially available transcatheter aortic valve</intervention_name>
    <description>Commercially available transcatheter aortic valve</description>
    <arm_group_label>Randomized IDE Cohort, CAV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Subjects must have co-morbidities such that the surgeon and cardiologist&#xD;
             Co-Investigators concur that the predicted risk of operative mortality is ≥15% or a&#xD;
             minimum Society of Thoracic Surgeons (STS) score of 8%. A candidate who does not meet&#xD;
             the STS score criteria of ≥ 8% can be included in the study if a peer review by at&#xD;
             least two surgeons concludes and documents that the patient's predicted risk of&#xD;
             operative mortality is ≥15%. The surgeon's assessment of operative comorbidities not&#xD;
             captured by the STS score must be documented in the study case report form as well as&#xD;
             in the patient medical record.&#xD;
&#xD;
          2. Subject is 21 years of age or older at the time of consent.&#xD;
&#xD;
          3. Subject has senile degenerative aortic valve stenosis with echocardiographically&#xD;
             derived criteria: mean gradient &gt;40 mmHg or jet velocity greater than 4.0 m/s or&#xD;
             Doppler Velocity Index &lt;0.25 and an initial aortic valve area (AVA) of ≤ 1.0 cm2&#xD;
             (indexed effective orifice area (EOA) ≤ 0.6 cm2/m2). (Qualifying AVA baseline&#xD;
             measurement must be within 60 days prior to informed consent).&#xD;
&#xD;
          4. Subject has symptomatic aortic stenosis as demonstrated by New York Heart Association&#xD;
             (NYHA) Functional Classification of II, III, or IV.&#xD;
&#xD;
          5. The subject has been informed of the nature of the study, agrees to its provisions and&#xD;
             has provided written informed consent as approved by the Institutional Review Board&#xD;
             (IRB) of the respective clinical site.&#xD;
&#xD;
          6. The subject and the treating physician agree that the subject will return for all&#xD;
             required post-procedure follow-up visits.&#xD;
&#xD;
          7. Subject's aortic annulus is 19-27mm diameter as measured by computerized tomography&#xD;
             (CT) conducted within 12 months prior to informed consent. Note: if CT is&#xD;
             contraindicated and/or not possible to be obtained for certain subjects, a 3D echo and&#xD;
             non-contrast CT of chest and abdomen/pelvis may be accepted if approved by the subject&#xD;
             selection committee.&#xD;
&#xD;
             For a subject to be considered an Extreme Risk candidate they must meet # 2, 3, 4, 5,&#xD;
             6, 7 of the above criteria, and&#xD;
&#xD;
          8. The subject, after formal consults by a cardiologist and two cardiovascular surgeons&#xD;
             agree that medical factors preclude operation, based on a conclusion that the&#xD;
             probability of death or serious, irreversible morbidity exceeds the probability of&#xD;
             meaningful improvement. Specifically, the probability of death or serious,&#xD;
             irreversible morbidity should exceed 50%. The surgeons' consult notes shall specify&#xD;
             the medical or anatomic factors leading to that conclusion and include a printout of&#xD;
             the calculation of the STS score to additionally identify the risks in these patients.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Evidence of an acute myocardial infarction (defined as: ST Segment Elevation as&#xD;
             evidenced on 12 Lead ECG) within 30 days prior to index procedure.&#xD;
&#xD;
          2. Aortic valve is a congenital unicuspid or congenital bicuspid valve or is&#xD;
             non-calcified as verified by echocardiography.&#xD;
&#xD;
          3. Mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant&#xD;
             aortic regurgitation 3-4+).&#xD;
&#xD;
          4. Any percutaneous coronary or peripheral interventional procedure performed within 30&#xD;
             days prior to index procedure.&#xD;
&#xD;
          5. Pre-existing prosthetic heart valve or other implant in any valve position, prosthetic&#xD;
             ring, severe circumferential mitral annular calcification (MAC) which is continuous&#xD;
             with calcium in the left ventricular outflow tract (LVOT), severe (greater than 3+)&#xD;
             mitral insufficiency, or severe mitral stenosis with pulmonary compromise. Subjects&#xD;
             with pre-existing surgical bioprosthetic aortic heart valve should be considered for&#xD;
             the Valve-in-Valve registry.&#xD;
&#xD;
          6. Blood dyscrasias as defined: leukopenia (WBC&lt;3000 mm3), acute anemia (Hb &lt; 9 g/dL),&#xD;
             thrombocytopenia (platelet count &lt;50,000 cells/mm³).&#xD;
&#xD;
          7. History of bleeding diathesis or coagulopathy.&#xD;
&#xD;
          8. Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or&#xD;
             mechanical hemodynamic support.&#xD;
&#xD;
          9. Untreated clinically significant coronary artery disease requiring revascularization.&#xD;
&#xD;
         10. Hemodynamic instability requiring inotropic support or mechanical heart assistance.&#xD;
&#xD;
         11. Need for emergency surgery for any reason.&#xD;
&#xD;
         12. Hypertrophic cardiomyopathy with or without obstruction (HOCM).&#xD;
&#xD;
         13. Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) &lt;20% as&#xD;
             measured by resting echocardiogram.&#xD;
&#xD;
         14. Echocardiographic evidence of intracardiac mass, thrombus or vegetation.&#xD;
&#xD;
         15. Active peptic ulcer or upper gastrointestinal (GI) bleeding within 3 months prior to&#xD;
             index procedure.&#xD;
&#xD;
         16. A known hypersensitivity or contraindication to aspirin, heparin, ticlopidine&#xD;
             (Ticlid), or clopidogrel (Plavix), or sensitivity to contrast media which cannot be&#xD;
             adequately premedicated.&#xD;
&#xD;
         17. Recent (within 6 months prior to index procedure date) cerebrovascular accident (CVA)&#xD;
             or a transient ischemic attack (TIA).&#xD;
&#xD;
         18. Renal insufficiency (creatinine &gt; 3.0 mg/dL) and/or end stage renal disease requiring&#xD;
             chronic dialysis.&#xD;
&#xD;
         19. Life expectancy &lt; 12 months from the time of informed consent due to non-cardiac&#xD;
             co-morbid conditions.&#xD;
&#xD;
         20. Significant aortic disease, including abdominal aortic or thoracic aneurysm defined as&#xD;
             maximal luminal diameter 5cm or greater; marked tortuosity (hyperacute bend), aortic&#xD;
             arch atheroma (especially if thick [&gt; 5 mm], protruding or ulcerated) or narrowing&#xD;
             (especially with calcification and surface irregularities) of the abdominal or&#xD;
             thoracic aorta, severe &quot;unfolding&quot; and tortuosity of the thoracic aorta (applicable&#xD;
             for transfemoral patients only).&#xD;
&#xD;
         21. Native aortic annulus size &lt; 19 mm or &gt; 27 mm per the baseline diagnostic imaging.&#xD;
&#xD;
         22. Aortic root angulation &gt; 70° (applicable for transfemoral patients only).&#xD;
&#xD;
         23. Currently participating in an investigational drug or device study.&#xD;
&#xD;
         24. Active bacterial endocarditis within 6 months prior to the index procedure.&#xD;
&#xD;
         25. Bulky calcified aortic valve leaflets in close proximity to coronary ostia.&#xD;
&#xD;
         26. Non-calcified aortic annulus&#xD;
&#xD;
         27. Iliofemoral vessel characteristics that would preclude safe placement of the&#xD;
             introducer sheath such as severe obstructive calcification, or severe tortuosity&#xD;
             (applicable for transfemoral patients only).&#xD;
&#xD;
        Additional Exclusion Criteria (Transcatheter Access Related)&#xD;
&#xD;
        For selection of an appropriate alternative access delivery method, subjects were screened&#xD;
        using the following access specific exclusion criteria:&#xD;
&#xD;
        Transaortic (TAo) Subject Cohort Specific Exclusion Criteria&#xD;
&#xD;
          1. Subject has pre-existing patent RIMA graft that would preclude access.&#xD;
&#xD;
          2. Subject has a hostile chest or other condition that complicates transaortic access.&#xD;
&#xD;
          3. Subject has a porcelain aorta, defined as an extensive circumferential calcification&#xD;
             of the ascending aorta that would complicate TAo access.&#xD;
&#xD;
        Additional exclusion criteria for transaortic access using the FlexNav™ Delivery System:&#xD;
&#xD;
          1. Subject has a distance between the annular plane and the aortic access site &lt;7 cm&#xD;
             (2.8&quot;)&#xD;
&#xD;
          2. Subject has a distance between the annular plane and the separate introducer sheath&#xD;
             distal tip &lt;6 cm (2.4&quot;)&#xD;
&#xD;
        Subclavian/Axillary Subject Cohort Specific Exclusion Criteria&#xD;
&#xD;
          1. Subject's access vessel (subclavian/axillary) diameter will not allow for introduction&#xD;
             of the applicable 18 Fr or 19 Fr delivery system.&#xD;
&#xD;
          2. Subject's subclavian/axillary arteries have severe calcification and/or tortuosity.&#xD;
&#xD;
          3. Subject's aortic root angulation is:&#xD;
&#xD;
               -  Left Subclavian/Left Axillary: &gt;70◦&#xD;
&#xD;
               -  Right Subclavian/Right Axillary: &gt;30◦&#xD;
&#xD;
          4. Subject has a history of patent LIMA/RIMA graft that would preclude access&#xD;
&#xD;
        Additional exclusion criteria for subclavian/axillary access using the FlexNav™ Delivery&#xD;
        System:&#xD;
&#xD;
          1. Subject's access vessel (subclavian/axillary) has a distance between the annular plane&#xD;
             and the integrated sheath distal tip &lt;17 cm (6.7&quot;)&#xD;
&#xD;
          2. Subject's access vessel requires the delivery system to be advanced through a separate&#xD;
             introducer sheath&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raj R Makkar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory P Fontana, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Los Robles Regional Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly S Behning</last_name>
    <phone>651-756-5622</phone>
    <email>kimberly.behning@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital - Univ. of Alabama at Birmingham (UAB)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Banner - University Medical Center Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ashish Pershad, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Muir Medical Center</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Scripps Green Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>USC University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Raj Makkar, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Huntington Memorial Hospital</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sutter Memorial Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Los Robles Regional Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul Corso, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ron Waksman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Morton Plant Valve Clinic</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Delray Medical Center</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ravi Ramana, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antone Tatooles, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>James Hermiller, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Heimansohn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Institute of Kansas</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bassem Chehab, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brett Grizzell, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sparrow Clinical Research Institute</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Norbert Baumgartner, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gaurav Dhar, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital Springfield</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lewis Britton, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Richard Schwartz, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital / Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mission Health and Hospitals</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark Groh, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>East Carolina Heart Institute</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Scott Lilly, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health System</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Allegheny Singer Research Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Main Line Health Center/Lankenau Hospital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sanford USD Medical Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baptist Memorial Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Edward Garrett, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centennial Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Seenu Reddy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Riddick, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Hospital of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHI St. Luke's Health Baylor College of Medicine Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joseph Coselli, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guilherme Silva, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Brown, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Brinkman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul Mahoney, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Macquarie University Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2109</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Prince Charles Hospital</name>
      <address>
        <city>Chermside</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stephen Worthley, MBBS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tony Walton, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gerald Yong, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>November 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2013</study_first_posted>
  <results_first_submitted>October 29, 2020</results_first_submitted>
  <results_first_submitted_qc>December 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 12, 2021</results_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Portico</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT02000115/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT02000115/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>750 subjects were randomized (1:1) to the Portico valve (n=381) and CAV (n=369) groups.&#xD;
100 analysis subjects were enrolled in the FlexNav Delivery System study.&#xD;
53 subjects are currently enrolled in the IDE Valve-in-Valve registry ( enrollment ongoing)</recruitment_details>
      <pre_assignment_details>Only the Randomized IDE cohort (N=750) and FlexNav Delivery System Study (N=100 analysis) that completed subject enrollment and reached their pre-defined primary endpoint(s) are included in the Results Section.&#xD;
The IDE Valve-in-Valve registry is still enrolling subjects. A total of 53 out of a required 100 subjects have been enrolled to date.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Randomized IDE Cohort, Portico Valve</title>
          <description>Portico transcatheter aortic valve and Portico delivery System.</description>
        </group>
        <group group_id="P2">
          <title>Randomized IDE Cohort, CAV</title>
          <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
        </group>
        <group group_id="P3">
          <title>FlexNav Delivery System Study</title>
          <description>Portico transcatheter aortic valve and FlexNav delivery system</description>
        </group>
        <group group_id="P4">
          <title>Nested Valve-in-Valve Registry</title>
          <description>Subjects who have documented failed aortic surgical valve prosthesis and are deemed eligible to receive a transcatheter Portico valve</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="381"/>
                <participants group_id="P2" count="369"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="302">6 subjects missed the One-year follow-up visit</participants>
                <participants group_id="P2" count="301">8 subjects missed the One-year follow-up visit</participants>
                <participants group_id="P3" count="99">1 subject missed the 30 day follow-up visit</participants>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="68"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="53"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed Visit</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawn on day of randomization</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Still on Study</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="53"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Randomized IDE cohort: analysis population includes all randomized subjects (intention-to-treat) FlexNav Delivery System study: analysis population includes all enrolled subjects (defined as insertion of FlexNav delivery system into subject's vasculature)</population>
      <group_list>
        <group group_id="B1">
          <title>Randomized IDE Cohort, Portico Valve</title>
          <description>Portico transcatheter aortic valve and Portico delivery system</description>
        </group>
        <group group_id="B2">
          <title>Randomized IDE Cohort, CAV</title>
          <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
        </group>
        <group group_id="B3">
          <title>FlexNav Delivery System Study</title>
          <description>Portico transcatheter aortic valve and FlexNav delivery system</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="381"/>
            <count group_id="B2" value="369"/>
            <count group_id="B3" value="100"/>
            <count group_id="B4" value="850"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.0" spread="7.6"/>
                    <measurement group_id="B2" value="83.7" spread="7.0"/>
                    <measurement group_id="B3" value="85.1" spread="5.8"/>
                    <measurement group_id="B4" value="83.5" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="198"/>
                    <measurement group_id="B2" value="197"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="452"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="398"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="354"/>
                    <measurement group_id="B2" value="339"/>
                    <measurement group_id="B3" value="92"/>
                    <measurement group_id="B4" value="785"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>American Indian or Alaska native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="351"/>
                    <measurement group_id="B2" value="340"/>
                    <measurement group_id="B3" value="75"/>
                    <measurement group_id="B4" value="796"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Effectiveness Endpoint (Randomized IDE Cohort)</title>
        <description>A composite of all-cause mortality or disabling stroke at one year.</description>
        <time_frame>One-year from randomization</time_frame>
        <population>Intention-to-treat analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Effectiveness Endpoint (Randomized IDE Cohort)</title>
          <description>A composite of all-cause mortality or disabling stroke at one year.</description>
          <population>Intention-to-treat analysis population.</population>
          <units>percentage of participants</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="381"/>
                <count group_id="O2" value="369"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" spread="1.8"/>
                    <measurement group_id="O2" value="13.4" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We analysed the primary effectiveness endpoint in the intention-to- treat (ITT) population using the Kaplan-Meier method to estimate event rates, the Greenwood method to calculate the standard error of the Kaplan-Meier estimates, and assuming an asymptotic normal distribution for event rate estimates.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>8.0% non-inferiority margin</non_inferiority_desc>
            <p_value>0.006</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>Kaplan-Meier estimates</method>
            <method_desc>Kaplan-Meier was used as the method for calculating the endpoint rate</method_desc>
            <param_type>Difference in percentages between groups</param_type>
            <param_value>1.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>5.7</ci_upper_limit>
            <estimate_desc>Non-inferiority of the Portico valve to commercially available valves was shown if the upper bound of the 95% confidence interval (1-sided) for the difference in event rates between groups was less than the non-inferiority margin (8·0%)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Safety Endpoint (Randomized IDE Cohort)</title>
        <description>Non-hierarchical composite of all-cause mortality, disabling stroke, life threatening bleeding requiring blood transfusion, acute kidney injury requiring dialysis, or major vascular complications at 30 days.</description>
        <time_frame>30 days from randomization</time_frame>
        <population>Intention-to-treat analysis population</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Safety Endpoint (Randomized IDE Cohort)</title>
          <description>Non-hierarchical composite of all-cause mortality, disabling stroke, life threatening bleeding requiring blood transfusion, acute kidney injury requiring dialysis, or major vascular complications at 30 days.</description>
          <population>Intention-to-treat analysis population</population>
          <units>percentage of participants</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="381"/>
                <count group_id="O2" value="369"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="1.8"/>
                    <measurement group_id="O2" value="9.6" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We analysed the primary safety endpoint in the intention-to-treat (ITT) population using the Kaplan-Meier method to estimate event rates, the Greenwood method to calculate the standard error of the Kaplan-Meier estimates, and assuming an asymptotic normal distribution for event rate estimates.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>8.5% non-inferiority margin</non_inferiority_desc>
            <p_value>0.03</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>Kaplan-Meier estimates</method>
            <method_desc>Kaplan-Meier was used as the method for calculating the endpoint rate</method_desc>
            <param_type>Difference in percentages between groups</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>8.1</ci_upper_limit>
            <estimate_desc>Non-inferiority of the Portico valve to commercially available valves was shown if the upper bound of the 95% confidence interval (1-sided) for the difference in event rates between groups was less than the non-inferiority margin (8·5%)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients With Major Vascular Complications (Primary Safety Endpoint- FlexNav Delivery System Study)</title>
        <description>Valve Academic Research Consortium (VARC) 2- defined major vascular complications</description>
        <time_frame>30 days from index procedure</time_frame>
        <population>All enrolled analysis subjects</population>
        <group_list>
          <group group_id="O1">
            <title>FlexNav Delivery System Study</title>
            <description>Portico transcatheter aortic valve and FlexNav delivery system</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Major Vascular Complications (Primary Safety Endpoint- FlexNav Delivery System Study)</title>
          <description>Valve Academic Research Consortium (VARC) 2- defined major vascular complications</description>
          <population>All enrolled analysis subjects</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With Severe Aortic Regurgitation (Randomized IDE Cohort)</title>
        <description>Severe aortic regurgitation (AR) at one year</description>
        <time_frame>One year</time_frame>
        <population>All randomized subjects with available data at one-year</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Severe Aortic Regurgitation (Randomized IDE Cohort)</title>
          <description>Severe aortic regurgitation (AR) at one year</description>
          <population>All randomized subjects with available data at one-year</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="269"/>
                <count group_id="O2" value="269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>non-inferiority margin of 4%</non_inferiority_desc>
            <p_value>0.001</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>Farrington-Manning test</method>
            <method_desc>The test statistic is based on the Farrington-Manning method of testing non-inferiority of proportions.</method_desc>
            <param_type>Difference in percentages between groups</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>2.3</ci_upper_limit>
            <estimate_desc>If the upper limit of the 95% confidence interval (1-sided) for the difference of proportions (Portico - CAV) is &lt; 4%, then non inferiority is demonstrated.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score (Randomized IDE Cohort)</title>
        <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) at one year. Scale 0 to 100; with higher scores indicating better symptoms and physical functioning</description>
        <time_frame>One year</time_frame>
        <population>All randomized subjects with available data at one-year</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
          </group>
        </group_list>
        <measure>
          <title>Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score (Randomized IDE Cohort)</title>
          <description>Kansas City Cardiomyopathy Questionnaire (KCCQ) at one year. Scale 0 to 100; with higher scores indicating better symptoms and physical functioning</description>
          <population>All randomized subjects with available data at one-year</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="274"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.4" spread="22.2"/>
                    <measurement group_id="O2" value="75.9" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>non-inferiority margin of 10 points</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>two-sample t-test</method>
            <method_desc>The test statistic is based on two sample t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_lower_limit>-3.5</ci_lower_limit>
            <estimate_desc>If the lower limit of the 95% confidence interval (1-sided) for the difference of (Portico - CAV) is &gt; -10, then non inferiority is demonstrated.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With Moderate or Severe Aortic Regurgitation (Randomized IDE Cohort)</title>
        <description>Moderate or severe aortic regurgitation at one year</description>
        <time_frame>One year</time_frame>
        <population>All randomized subjects with available data at one-year</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Moderate or Severe Aortic Regurgitation (Randomized IDE Cohort)</title>
          <description>Moderate or severe aortic regurgitation at one year</description>
          <population>All randomized subjects with available data at one-year</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="269"/>
                <count group_id="O2" value="269"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1"/>
                    <measurement group_id="O2" value="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>non-inferiority margin of 6%</non_inferiority_desc>
            <p_value>0.40</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>Farrington-Manning test</method>
            <method_desc>The test statistic is based on the Farrington-Manning method of testing non-inferiority of proportions</method_desc>
            <param_type>Difference in percentages between groups</param_type>
            <param_value>5.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>8.5</ci_upper_limit>
            <estimate_desc>If the upper limit of the 95% confidence interval (1-sided) for the difference of proportions (Portico - CAV) is &lt; 6%, then non inferiority is demonstrated.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Six-Minute Walk Test- Total Distance Walked (Randomized IDE Cohort)</title>
        <description>Six-minute walk distance at one year</description>
        <time_frame>One year</time_frame>
        <population>All randomized subjects with available data at one-year</population>
        <group_list>
          <group group_id="O1">
            <title>Randomized IDE Cohort, Portico Valve</title>
            <description>Portico transcatheter aortic valve and Portico delivery system</description>
          </group>
          <group group_id="O2">
            <title>Randomized IDE Cohort, CAV</title>
            <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).&#xD;
Status: ACTIVE, NOT ENROLLING.&#xD;
Commercially available transcatheter aortic valve: Commercially available transcatheter aortic valve</description>
          </group>
        </group_list>
        <measure>
          <title>Six-Minute Walk Test- Total Distance Walked (Randomized IDE Cohort)</title>
          <description>Six-minute walk distance at one year</description>
          <population>All randomized subjects with available data at one-year</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="227"/>
                <count group_id="O2" value="225"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235.0" spread="125.0"/>
                    <measurement group_id="O2" value="231.5" spread="118.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>non-inferiority margin on -36 meters</non_inferiority_desc>
            <p_value>0.0003</p_value>
            <p_value_desc>p for non-inferiority</p_value_desc>
            <method>two sample t-test</method>
            <method_desc>The test statistic is based on a two-sample t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_lower_limit>-15.4</ci_lower_limit>
            <estimate_desc>If the lower limit of the 95% confidence interval (1-sided) for the difference of (Portico - CAV) is &gt; -36, then non inferiority is demonstrated.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With Composite Safety Endpoint (Nested Valve-in-Valve Registry)</title>
        <description>Non-hierarchical composite of all-cause mortality, disabling stroke, life threatening bleeding requiring blood transfusion, acute kidney injury requiring dialysis, or major vascular complications at 30 days from index procedure.&#xD;
Anticipated completion date (2022)</description>
        <time_frame>30 days from index procedure</time_frame>
        <posting_date>12/2022</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With All-cause Mortality or Disabling Stroke (Nested Valve-in-Valve Registry)</title>
        <description>A composite of all-cause mortality or disabling stroke at one year Anticipated completion data (2023)</description>
        <time_frame>One year from index procedure</time_frame>
        <posting_date>12/2023</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Randomized IDE cohort: data reflects all serious and other (non serious) adverse events through 1 year in the intention-to-treat population (i.e. within 365 days of randomization); and all-cause mortality reflects all deaths through 1 year. FlexNav Delivery System study: data reflects all serious and other (non serious) adverse events through 30 days in the enrolled analysis population (i.e. within 30 days from index procedure); and all-cause mortality reflects all deaths through 30 days</time_frame>
      <desc>Site-reported Serious and Other (Not Including Serious) Adverse Events reflect data collected from the intention-to-treat population (RCT) or enrolled analysis population (FlexNav Delivery System Study); while All-Cause Mortality reflects the entire population</desc>
      <group_list>
        <group group_id="E1">
          <title>Randomized IDE Cohort, Portico Valve</title>
          <description>Portico transcatheter aortic valve and Portico delivery system</description>
        </group>
        <group group_id="E2">
          <title>Randomized IDE Cohort, CAV</title>
          <description>Any FDA approved, commercially-available transcatheter aortic valve (CAV).</description>
        </group>
        <group group_id="E3">
          <title>FlexNav Delivery System Study</title>
          <description>Portico transcatheter aortic valve and FlexNav delivery system</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="381"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="369"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="273" subjects_at_risk="381"/>
                <counts group_id="E2" subjects_affected="231" subjects_at_risk="369"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemias</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="381"/>
                <counts group_id="E2" events="35" subjects_affected="32" subjects_at_risk="369"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Hematology and Oncology</sub_title>
                <counts group_id="E1" events="48" subjects_affected="43" subjects_at_risk="381"/>
                <counts group_id="E2" events="29" subjects_affected="21" subjects_at_risk="369"/>
                <counts group_id="E3" events="18" subjects_affected="13" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" events="14" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Aorta- Aortic Calcification</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Aortic- Aortic Dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Arrhythmias</sub_title>
                <counts group_id="E1" events="43" subjects_affected="38" subjects_at_risk="381"/>
                <counts group_id="E2" events="42" subjects_affected="34" subjects_at_risk="369"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Arterial Hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>EKG Abnormalities</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Echo finding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Endocarditis- Infective/Bacterial Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Endocarditis- Prosthetic Valvular Endocarditis (PVE)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Asystole</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Cardiac Arrest</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Cardiac Perforation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Hypervolemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Myocardial Ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Pericardial Effusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Pericardial Tamponade</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Pulmonary Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Cardiovascular Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Heart Block</sub_title>
                <counts group_id="E1" events="102" subjects_affected="98" subjects_at_risk="381"/>
                <counts group_id="E2" events="39" subjects_affected="37" subjects_at_risk="369"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" events="79" subjects_affected="56" subjects_at_risk="381"/>
                <counts group_id="E2" events="52" subjects_affected="39" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="381"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Aortic Valve Regurgitation/Aortic Valve Insufficiency/Valvular Regurgitation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Mitral Valve Regurgitation/Mitral Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Mitral Valve Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Perivalvular Leak</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="381"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Tricuspid Regurgitation/Tricuspid Insufficiency/Valvular Regurgitation Tricuspid Valve</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hypovolemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Esophageal Laceration and Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Gastrointestinal Disorders</sub_title>
                <counts group_id="E1" events="36" subjects_affected="31" subjects_at_risk="381"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Gastrointestinal Symptoms</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hepatic and Biliary Disorders</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Nose and Paranasal Sinuses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Throat- Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Allergy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Miscellaneous- General</sub_title>
                <counts group_id="E1" events="68" subjects_affected="60" subjects_at_risk="381"/>
                <counts group_id="E2" events="70" subjects_affected="60" subjects_at_risk="369"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Fungal Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Infections</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="381"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>VASC Bleeding</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vascular Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vessel Dissection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vessel Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vessel Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Disorders of Carbohydrate Metabolism</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="381"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Fluid, Electrolyte, Endocine and Metabolic Disorders</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="381"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Musculoskeletal and Connective Tissue Disorders</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Musculoskeletal Symptoms</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>General-Neurological</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="381"/>
                <counts group_id="E2" events="25" subjects_affected="18" subjects_at_risk="369"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Neurological Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Neurological Hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Seizure/Convulsions/Epilepsy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Miscellaneous- Device Malposition or Malfunction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Miscellaneous- Device Migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Miscellaneous-Thrombus on Device</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>General-Genitourinary Disorders</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="381"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Genitourinary Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Prostate Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="381"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Airway Disorders</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Pulmonary/Respiratory Disorders</sub_title>
                <counts group_id="E1" events="48" subjects_affected="36" subjects_at_risk="381"/>
                <counts group_id="E2" events="28" subjects_affected="26" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Eosinophilic Pneumonias</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Idiopathic Interstitial Lung Diseases</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Pleural Disorders</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="381"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="369"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="29" subjects_affected="26" subjects_at_risk="381"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Dematological</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="298" subjects_at_risk="381"/>
                <counts group_id="E2" subjects_affected="269" subjects_at_risk="369"/>
                <counts group_id="E3" subjects_affected="54" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemias</sub_title>
                <counts group_id="E1" events="48" subjects_affected="46" subjects_at_risk="381"/>
                <counts group_id="E2" events="40" subjects_affected="40" subjects_at_risk="369"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Hematology and Oncology</sub_title>
                <counts group_id="E1" events="105" subjects_affected="87" subjects_at_risk="381"/>
                <counts group_id="E2" events="65" subjects_affected="56" subjects_at_risk="369"/>
                <counts group_id="E3" events="18" subjects_affected="17" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Aortic-Aortic Dissection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Arrhythmias</sub_title>
                <counts group_id="E1" events="60" subjects_affected="54" subjects_at_risk="381"/>
                <counts group_id="E2" events="50" subjects_affected="45" subjects_at_risk="369"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Arterial Hypertension</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="381"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>EKG Abnormalities</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Echo Finding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="381"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="369"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Cardiovascular Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Heart Block</sub_title>
                <counts group_id="E1" events="114" subjects_affected="102" subjects_at_risk="381"/>
                <counts group_id="E2" events="91" subjects_affected="83" subjects_at_risk="369"/>
                <counts group_id="E3" events="20" subjects_affected="19" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="381"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="381"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve-Aortic Valve Regurgitation/Aortic Valve Insufficiency/Valvular Regurgitation Aortic Valve</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="381"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Mitral Valve Regurgitation/Mitral Insufficiency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve- Perivalvular Leak</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="381"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Valve-Tricuspid Regurgitation/Tricuspid Insufficiency/Valvular Regurgitation Tricuspid Valve</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>General- Opthalmologic Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Opthalmic Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Esophageal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="381"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Gastrointestinal Symptoms</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hepatic and Biliary Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dental Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Nose and Paranasal Sinuses</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Throat</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Allergy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Miscellaneous</sub_title>
                <counts group_id="E1" events="111" subjects_affected="87" subjects_at_risk="381"/>
                <counts group_id="E2" events="81" subjects_affected="68" subjects_at_risk="369"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Fungal Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Infections</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Viral</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>VASC Bleeding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Irreversible Nerve Damage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vessel Dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>VASC Vessel Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Disorders of Carbohydrate Metabolism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Fluid, Electrolyte, Endocrine and Metabolic Disorders</sub_title>
                <counts group_id="E1" events="34" subjects_affected="26" subjects_at_risk="381"/>
                <counts group_id="E2" events="22" subjects_affected="18" subjects_at_risk="369"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Thyroid Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Achilles Tendon Tear</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="381"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="381"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Musculoskeletal Symptoms</sub_title>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="381"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>General-Neurological</sub_title>
                <counts group_id="E1" events="28" subjects_affected="26" subjects_at_risk="381"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Neurological Symptoms</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="381"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="369"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Acute Subdural Hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Malposition or Malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Device Migration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Thrombus on Device</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="381"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>General- Genitourinary Disorders</sub_title>
                <counts group_id="E1" events="40" subjects_affected="35" subjects_at_risk="381"/>
                <counts group_id="E2" events="42" subjects_affected="41" subjects_at_risk="369"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Genitourinary Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Myoneurogenic Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Prostate Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" events="36" subjects_affected="33" subjects_at_risk="381"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Airway Disorders</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="381"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General- Pulmonary/Respiratory Disorders</sub_title>
                <counts group_id="E1" events="29" subjects_affected="27" subjects_at_risk="381"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="369"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Idiopathic Interstitial Lung Diseases</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Pleural Disorders</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="381"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="381"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>X-ray Finding</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="381"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="381"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>General-Dermatogical</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="381"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="369"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="381"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="369"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alicia Kimber, PhD</name_or_title>
      <organization>Abbott Structural Heart</organization>
      <phone>224-229-7758</phone>
      <email>alicia.kimber@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

